An interventional study of whole body vibration and traditional exercise group in Patellofemoral Pain Syndrome, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2023-08-30.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 30 studies in Patellofemoral Pain Syndrome by Cairo University — 12 open to participants now, 13 under way, none of them phase 3. Patellofemoral Pain Syndrome · Cairo University.
Among the 30 studies in Patellofemoral Pain Syndrome by Cairo University, this one is the 5th largest by planned enrollment of the 22 interventional ones that give a count, is one of 6 that started in 2023, is one of 22 with no phase, reaches primary completion later than 0 of the 12 other live ones, and was the 12th registered.
297 studies on the registry are indexed under Patellofemoral Pain Syndrome; 73 are open to participants now.
Browse Patellofemoral Pain Syndrome studies →12 of the 30 studies in Patellofemoral Pain Syndrome by Cairo University are open now, in 3 countries. Recruiting first, the newest first:
Cairo University · Sites in Lebanon
Ages 18–50
Cairo University · Sites in Egypt
Ages 18–30
Cairo University · Sites in Egypt
Ages 18–35
Cairo University · Sites in Egypt
Ages 18–35
Cairo University · Sites in Egypt
Ages 18–40
By country, each count listing its studies:
Of the 44 Patellofemoral Pain Syndrome studies recruiting now, 3 (7%) set no upper age limit and 40 (91%) stop at 75 or younger; 6 take children under 18; 12 take healthy volunteers.
This study: 18 Years to 35 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
30 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 6 started in 2023.
This study's planned enrollment of 60 is above the median of 45 across 244 interventional studies indexed under Patellofemoral Pain Syndrome.
Median enrollment 58 across the 22 interventional studies, 53 across the 8 observational. Of the 12 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
2 of the studies in Patellofemoral Pain Syndrome by Cairo University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07664566Cairo UniversityCore Stability Exercises Versus Proprioceptive Training on Pain and Function in Patients With Patellofemoral Pain Syndrome | 2027-03-20 |
| NCT07806929Cairo UniversityComparison Between Foot Segment Mulligan Mobilization and Ilium Mulligan Mobilization in Treatment Patellofemoral Pain Patients With Flatfeet: a Randomized Controlled Comparative Study | 2027-11-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 30 studies in Patellofemoral Pain Syndrome by Cairo University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Patellofemoral pain syndrome (PFPS) can significantly affect an individual's ability perform to functional activities, such as walking, running, climbing stairs, and sitting for prolonged periods.
PFPS is often associated with pain and discomfort in the front of the knee, which can limit an individual's range of motion and cause difficulty with weight-bearing activities. The pain may also be exacerbated by activities that involve bending the knee, such as squatting or kneeling.
Whole body vibration (WBV) has been suggested as a potential intervention for patellofemoral pain syndrome (PFPS). Some studies have shown that WBV can improve muscle strength, balance, and proprioception, which are all factors that may contribute to PFPS. Additionally, WBV may help reduce pain and improve functional abilities in individuals with PFPS However, the evidence for the effectiveness of WBV as an intervention for PFPS is still limited, and more research is needed to fully understand its potential benefits and limitations. It is important to note that WBV may not be suitable for all individuals with PFPS.
Patellofemoral pain syndrome (PFPS) can significantly affect an individual's ability perform to functional activities, such as walking, running, climbing stairs, and sitting for prolonged periods.
PFPS is often associated with pain and discomfort in the front of the knee, which can limit an individual's range of motion and cause difficulty with weight-bearing activities. The pain may also be exacerbated by activities that involve bending the knee, such as squatting or kneeling.
Whole body vibration (WBV) has been suggested as a potential intervention for patellofemoral pain syndrome (PFPS). Some studies have shown that WBV can improve muscle strength, balance, and proprioception, which are all factors that may contribute to PFPS. Additionally, WBV may help reduce pain and improve functional abilities in individuals with PFPS.
However, the evidence for the effectiveness of WBV as an intervention for PFPS is still limited, and more research is needed to fully understand its potential benefits and limitations. It is important to note that WBV may not be suitable for all individuals with PFPS.
HYPOTHESES:
There will be no significant difference on dorsi/planter flexor ratio , functional activities and pain level after adding the whole body vibration to traditional treatment of PFPS
RESEARCH QUESTION:
What is the impact of whole-body vibration on dorsi/planter flexor ratio, functional activities and pain levels in individuals with PFPS?
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: whole body vibration · Other: traditional exercise group
Other: traditional exercise group
patients will receive WBV training in addition to traditional training will be performed on a tri-planar (mostly vertical, Z axis) oscillating vibration platform (Power PlateR pro5™; Power Plate North America, Inc., Northbrook, IL,USA) for 20-30 minutes per session. WBV training will be supervised and performed in a clinic three days a week with at least one day between each session for four weeks (total of 12 sessions).
10 minutes warm-up (lower extremity stretching exercises), 20-30 minutes period of strength exercises with three sets of 10-15 repetitions (isometric quadriceps setting, knee extensions, double-legged wall squat), and 5 minutes cool-down (lower extremity stretching exercises). Lower extremity stretching exercises consisted of quadriceps, hamstring, gastrocnemius and iliotibial band stretching with 3 repetitions for 30 s each muscle.
Dorsi/planter torque ratio
dorsi/planter torque ratio will be measured through the Biodex System 4-Pro Isokinetic Strength Dynamometer for assessment of muscle torque
Time frame: one month
functional activities
Kujala Anterior Knee Pain Scale, which includes questions related to functional activities.
Time frame: one month
Pain intensity
10 cm Visual Analogue Scale (VAS) was used to assess pain intensity during activity in patients with patellofemoral pain (PFP). The scale ranged from 0, indicating "no pain," to 100, representing the "worst pain imaginable.
Time frame: one month
Plan to share: Yes
Supporting information: Study protocol, Informed consent form
Time frame: 6 months after publication
Access criteria: study protocol
No publications or documents are linked to this record.
Start is estimated for Aug 2023; primary completion for Oct 2023, 2 months later.
Of 153 non-industry interventional studies with no phase under Patellofemoral Pain Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 21. This study's planned 2 months is below that.
Counting every sponsor, half of 157 studies reached it within 11 months; a quarter within 4 and three quarters within 21.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Patellofemoral Pain Syndrome →